Efficacy of plasmapheresis on donor‐specific antibody reduction by <scp>HLA</scp> specificity in post–kidney transplant recipients
Chisa Yamada(University of Michigan), Robertson D. Davenport(University of Michigan), Milagros Samaniego(Henry Ford Health System), Randall S. Sung(University of Michigan), Alan B. Leichtman(University of Michigan), Marília Cascalho(University of Michigan), Daniel S. Ramón(University of Michigan)
Cited by 54
Related Papers
Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase
|Nature|1990|2k
KDOQI Clinical Practice Guideline for Hemodialysis Adequacy: 2015 Update
|American Journal of Kidney Diseases|2015|1.3k
Kidney Transplantation as Primary Therapy for End-Stage Renal Disease
|Clinical Journal of the American Society of Nephrology|2008|623
Plasmapheresis, CMV Hyperimmune Globulin, and Anti-CD20 Allow ABO-Incompatible Renal Transplantation Without Splenectomy
|American Journal of Transplantation|2004|283
Adverse Outcomes of Tacrolimus Withdrawal in Immune–Quiescent Kidney Transplant Recipients
|Journal of the American Society of Nephrology|2015|193